Altis Labs Series A: $25M

Sep 20, 2026Public sources — Collected from public sources, not yet cross-checked.

Altis Labs raised $25 million in a series a round led by OrbiMed and Qiming Venture Partners USA, announced Sept. 20.

Facts

Company: Altis Labs
Amount: $25 million
Currency: USD
Stage: Series A
Announced: Sep 20, 2026
Instrument: Equity

Investors

Led by: OrbiMed Qiming Venture Partners USA

Use of funds

Expand AI models to more cancer types, deploy with more global biopharmaceutical partners, and establish AI endpoints as a standard for oncology trials.

As stated by the company.

Sources

1.Altis Labs raises $25 million USD Series A to expand AI for cancer trials — BetaKit, Sep 21, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026